Employers Holdings, Inc. (EIG) Earnings
Employers Holdings, Inc. is expected to report next earnings on October 29, 2026 (in NaN days), with a consensus EPS estimate of $0.61. EIG has beaten EPS estimates in 7 of its last 12 reported quarters (average surprise -49.8% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Jul 30, 2026 | $0.57 | $0.70 | +23.2% | $220M | +8.2% |
| Apr 30, 2026 | $0.55 | $0.53 | -3.3% | $208M | -2.6% |
| Feb 19, 2026 | $0.41 | $0.66 | +61.0% | $170M | -21.7% |
| Oct 30, 2025 | $0.61 | $-1.10 | -280.3% | $239M | +10.1% |
| Jul 30, 2025 | $0.94 | $0.48 | -48.9% | $246M | +13.1% |
| May 1, 2025 | $0.69 | $0.87 | +26.1% | $203M | -7.0% |
| Feb 20, 2025 | $1.08 | $1.15 | +6.5% | $217M | -2.1% |
| Jul 31, 2024 | $1.09 | $1.10 | +1.2% | $217M | -3.5% |
| Apr 25, 2024 | $0.69 | $0.67 | -2.8% | $223M | -0.2% |
| Feb 15, 2024 | $1.08 | $1.40 | +29.6% | $226M | +4.8% |
| Oct 25, 2023 | $0.69 | $0.68 | -1.4% | $204M | -5.2% |
| Jul 26, 2023 | $0.96 | $1.17 | +21.9% | $215M | +2.1% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q2 FY2026 · July 30, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
- Executive and Board Updates • Welcomed Stephanie Bush to the Board of Directors and Jeff Lisenby as new General Counsel, with a core priority on attracting and retaining high-quality leadership. - Recapitalization and Capital Deployment • Full benefits of the firm's recapitalization are now visible, with accretive share repurchases driving the gap between flat net income and strong per-share earnings growth. • During Q2 2026, the firm repurchased 651,752 common shares for $28 million at an average price of $42.43 per share, representing a 17% discount to beginning book value per share and an 18% discount to beginning adjusted book value per share. • The Board declared a Q3 2026 dividend of $0.34 per share, maintaining the 6.25% increase implemented last quarter. - Underwriting and Reserve Strategy • The firm is actively prioritizing profitability over premium volume, focusing on its core small business workers' compensation segment and exiting non-core customer segments and geographies. • Q2 2026 actuarial review came in as expected, with no changes to loss reserves for 2025 and prior accident years. The current accident year loss and LAE ratio (excluding LPT, on voluntary business) was maintained at 72%, consistent with full-year 2025 levels. • California's approved 6.6% advisory pure premium rate increase (effective September 1, 2026) is not expected to materially impact Employer Holdings' results, as the firm was already ahead of the curve on rate adequacy in its largest market. - Product Expansion • Successfully launched a new excess workers compensation product line, writing its first policy in June 2026. Early results are strong, with over 200 policy submissions and 20 bound policies generating $4 million in premium in July 2026. • Next product expansion will focus on adding loss-sensitive offerings including large deductible workers' compensation products to diversify the firm's book, add cycle optionality, and grow new business. - Technology and Efficiency • Continued progress on key technology initiatives, including a major claim system upgrade, new CRM system, and ongoing rollout of internal AI tools. • Achieved a 94% staff adoption rate for AI tools, with multiple AI-assisted use cases already delivering tangible positive return on investment.
Guidance
Management did not issue explicit numerical full-year guidance or revisions to prior guidance in this call. Key forward-looking outlooks include: • Management expects the new excess workers compensation product line to deliver steady growth, supported by strong early submission flow and broker interest, though July's $4 million premium level is not expected to be sustained monthly. • The firm will remain an active share repurchaser through its authorized $125 million program (running through end of 2027, with $113 million remaining capacity), accelerating repurchases if the stock price declines and maintaining prudent, ROI-driven purchasing. • Management enters H2 2026 with accelerating new business pipeline momentum, with underwriting discipline expected to remain solid and the renewal book performing in line with expectations. • AI adoption is expected to continue driving efficiency gains across the business, and will be leveraged to support development of the new large deductible product line.
Segment performance
This transcript does not break out performance for multiple distinct product segments. Core workers' compensation small business segment net premium earned declined 12% year-over-year, and policies in force declined 5% as the firm prioritized profitability over volume. New excess workers compensation product launched in June 2026, with $4 million in written premium in July 2026 from 20 bound policies. Overall firm-level Q2 2026 performance: Gross premiums written totaled $163 million, a 20% decrease from $203 million in the prior-year quarter. Losses and loss adjustment expenses (LAE) were $122 million, down from $140 million year-over-year. Commission expense was $22 million, down from $26 million year-over-year. Underwriting expenses were $40 million, an 8% decrease from $43 million year-over-year. Net investment income was $27 million, up 1% year-over-year. Adjusted net income was $13 million, up from $12 million year-over-year. Diluted earnings per share grew 29% year-over-year, and adjusted earnings per share grew 46% year-over-year. Book value per share (including deferred gain) grew 9% year-over-year to $52.58.
Risks & headwinds
• Cumulative trauma (CT) claims in recent accident years create higher uncertainty for reserve levels, particularly given the firm's larger exposure to California relative to the broader industry. Management maintains a conservative reserve position to protect the balance sheet against this uncertainty. • There is irrational competitive pricing behavior in certain jurisdictions, especially in the middle market from package writers, leading the firm to turn down business that does not meet required margin targets and driving faster-than-expected premium volume declines. • All forward-looking statements are subject to inherent risks and uncertainties that could cause actual results to differ materially from expectations, with relevant risks detailed in the firm's SEC filings.
Analyst Q&A
Q: What impact will California's 6.6% approved rate increase have on Employer Holdings, and how is competition trending overall? /
A: Management states the firm already achieved adequate pricing ahead of the approved increase, so it will not materially impact their results. Overall, competition is particularly fierce from package writers in the middle market, with irrational pricing in some jurisdictions. The firm prioritizes margins over volume, turning away unprofitable business, which explains larger premium declines than policy count declines. Countrywide, the firm has achieved 5% year-over-year renewal rate increases, with flat national payrolls.
Q: Why isn't Employer Holdings releasing reserves like many peers, especially given CT claim risk? /
A: Every book of business is different, and Employer Holdings has a larger weight of California exposure than the broader industry. Given uncertainty around cumulative trauma claims in more recent accident years, management intentionally maintains a conservative, cautious reserve position to protect the balance sheet. Favorable reserve development continues to emerge as expected for older accident years.
Q: What is the outlook for the new excess workers compensation product, and what is the firm's share repurchase strategy? /
A: Early performance of the excess product is strong, with strong broker interest and submission flow; July's $4 million premium is elevated by the large July 1 renewal date for the target public entity segment, so that monthly level is not expected to continue. For repurchases, the firm has $113 million remaining capacity out of a $125 million program authorized through end of 2027. Management will remain an active, prudent repurchaser, accelerating purchases if the stock price declines, guided by return on investment given the current stock price trades below the firm's estimate of intrinsic value.
Q: What is the latest update on underlying medical inflation outside of CT claims? /
A: Management reports overall medical inflation in the workers' compensation space is currently benign, with no alarming trends emerging. No concerning impacts from tariffs on medical prices have appeared, and internal monitoring of prescription drug prices also shows no concerning shifts, aligned with recent industry economic research showing similar calm conditions.